Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Event Type
Facet Toggle
Time Frame
Facet Toggle
Time Frame
Facet Toggle
Blog Post
October 29, 2024
On the 14th October, the Lancet Commission on Investing in Health (CIH) released its third report (CIH 3.0). In this blog, we argue the reports’ approach to setting priorities globally and by burden of disease, combined with historically determined and (perhaps) politically negotiated modular healt...
Blog Post
July 24, 2023
The UK has much to learn from its performance during the COVID-19 pandemic as well as its extensive involvement in the 2014 West African Ebola outbreak. Important questions linger as to why the UK—a world-leader in public health, and a country in possession of a flourishing biological research secto...
Blog Post
August 25, 2022
The Russian invasion of Ukraine has created a historic lacuna for European security. A neglected dimension of the wider security conversation is the war’s consequences for global health security. We map these emerging threats from food insecurity to radiation risks, and call for the immediate develo...
Blog Post
January 05, 2022
The COVID-19 pandemic has laid bare the realpolitik of global health security. It has also illuminated some uncomfortable truths. In this blog, we explore China’s global health leadership, its international cooperation and lack thereof, and analyse what we see as the future of global health sec...
Blog Post
March 09, 2020
As the international community grapples with COVID-19 and the extent to which countries should fund outbreak preparedness, governments also continue to face day-to-day healthcare funding decisions, including for cancer treatments. As policymakers increasingly take cancer seriously, and allocate a gr...
CGD NOTES
April 08, 2019
Criticising cancer medicine pricing as too high is what football fans know as an "open goal"—a target that is hard to miss. Yet somehow the World Health Organization Technical Report on Cancer Pricing manages to do just that with a paper to the WHO Executive Board calling for pri...
